Related Experiment Video
Updated: Jun 9, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Insights into FACT in Cancers with Targeted Therapeutic Implications
Priyanka Barman1, Sukesh R Bhaumik1
1Division of Biochemistry and Molecular Biology, Department of Biomedical Sciences, Southern Illinois University School of Medicine, Carbondale, Illinois, USA.
Facilitates chromatin transcription (FACT) is a key regulator of DNA processes. Upregulated FACT drives cancer development and progression, highlighting its potential as a cancer biomarker and therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Chromatin Dynamics
Background:
- Facilitates chromatin transcription (FACT) is an ATP-independent chromatin remodeler.
- FACT regulates chromatin assembly/disassembly, impacting transcription, replication, and repair.
- FACT is unexpectedly upregulated in diverse cancers.
Purpose of the Study:
- To elucidate the role of FACT in various cancers.
- To provide mechanistic insights into FACT's oncogenic functions.
- To explore FACT as a potential therapeutic target in oncology.
Main Methods:
- Review of existing literature on FACT function and cancer biology.
- Analysis of studies reporting FACT upregulation in cancer.
- Discussion of mechanistic pathways linking FACT to oncogenesis.
Main Results:
- Upregulated FACT promotes oncogenesis, cancer cell survival, and metastasis.
- FACT acts as a prognostic marker in several cancer types.
- Mechanistic insights reveal FACT's critical role in cancer aggressiveness.
Conclusions:
- FACT is a significant driver of cancer progression.
- Targeting FACT presents a promising therapeutic strategy for cancer treatment.
- FACT holds potential as a predictive biomarker for cancer prognosis.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
